Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 2,421,452 | 2,129,751 | 1,965,851 | 1,827,780 | 1,723,473 |
| Cost of Goods | 291,887 | 279,245 | 258,527 | 234,696 | 230,728 |
| Gross Profit | 2,129,565 | 1,850,506 | 1,707,324 | 1,593,084 | 1,492,745 |
| Operating Expenses | 1,141,727 | 1,179,403 | 1,050,034 | 909,249 | 830,946 |
| Operating Income | 988,725 | 671,348 | 657,917 | 684,531 | 662,527 |
| Other Income | 2,928 | -13,206 | -10,305 | -10,810 | -12,717 |
| Pre-tax Income | 991,653 | 658,142 | 647,612 | 673,721 | 649,810 |
| Income Tax | 268,521 | 178,414 | 190,247 | 186,105 | 159,140 |
| Net Income Continuous | 723,132 | 479,728 | 457,365 | 487,616 | 490,670 |
| Minority Interests | 8,626 | -228 | N/A | N/A | N/A |
| Net Income | $714,506 | $479,956 | $457,265 | $487,616 | $490,670 |
| EPS Basic Total Ops | 3.02 | 2.03 | 1.93 | 2.06 | 2.07 |
| EPS Basic Continuous Ops | 3.06 | 2.03 | 1.94 | 2.06 | 2.07 |
| EPS Diluted Total Ops | 3.01 | 2.02 | 1.91 | 2.05 | 2.06 |
| EPS Diluted Continuous Ops | 3.05 | 2.02 | 1.92 | 2.05 | 2.06 |
| EBITDA(a) | $1,152,864 | $862,311 | $816,160 | $832,008 | $790,954 |